background
banner

HYLASE "DESSAU" 1500 I.U. Price

Active Substance: hyaluronidase.

725
UAD , based on 7541 reviews.
View Drug details

Overview

Welcome to Dwaey, specifically on HYLASE "DESSAU" 1500 I.U. Powder for solution for injection page.
This medicine contains an important and useful components, as it consists of hyaluronidase.
HYLASE "DESSAU" 1500 I.U. is available in the market in concentration 1500 IU / Vial and in the form of Powder for solution for injection .

RIEMSER PHARMA GmbH is the producer of HYLASE "DESSAU" 1500 I.U. and it is imported from GERMANY, The most popular alternatives of HYLASE "DESSAU" 1500 I.U. are listed downward .

Mode Of Action

Hyaluronidase is an enzyme which reduces the viscosity of ground substance, thus making the tissues more permeable to injected fluids. It facilitates distribution and absorption of locally injected substances. It also promotes resorption of excess fluids and extravasated blood in the tissues.

Indication

  • Hypodermoclysis
  • Facilitate SC/IM inj
  • Aid in dispersal of extravasated fluids or blood
  • Aid in diffusion of local anesthesia in ophthalmology

Precaution

Impaired renal function. Infants, elderly. Patients with infections. Pregnancy, lactation. Lactation: It is not known whether hyaluronidase is excreted in human milk; caution should be exercised

Side Effects

  • <1% Angioedema
  • urticaria
  • allergic reactions (<0.1%) Frequency Not Defined Edema
  • Local injection site reactions Potentially Fatal: Hypersensitivity and anaphylaxis.

Contra indication

Hypersensitivity, malignancy. Direct application to the cornea, reduction of swelling of bites or stings. Inj into or around infected area. IV admin; unexplained premature labour.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Action potentiated by urokinase especially in the treatment of MI. May increase absorption and toxicity of local anaesthetics. Heparin, salicylates and NSAIDs may inhibit the spreading action and efficacy of hyaluronidase.

Alternatives Price List

  • HYLASE "DESSAU" 1500 I.U.UAD 725
  • HYALASE 1500 IU UAD 522

Releated Products

banner

Report Price Error

Please feel welcome to contact Us with any price or medical error. Our doctors will receive any reports.